BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 27, 2026
Home » Topics » Analysis and data insight, Medical technology

Analysis and data insight, Medical technology
Analysis and data insight, Medical technology RSS Feed RSS

DNA with bar chart
Med-tech deals January 2024

January launches med-tech firms with $100M in deals, $1.43B in M&As

Feb. 9, 2024
By Amanda Lanier
The new year kicked off with med-tech deal value in January totaling $107.75 million. By the numbers, January’s 183 deals surpassed the 2023 monthly average of approximately 142 deals per month.
Read More

Med-tech gainers and losers for Jan. 29-Feb. 2, 2024

Feb. 5, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More
med-tech financings
Med-tech financings January 2024

Med-tech financings maintain momentum with $1B raised in January

Feb. 5, 2024
By Amanda Lanier
In the first month of 2024, med-tech financings passed the $1 billion mark once more, raising a total of $1.06 billion through 46 transactions recorded by BioWorld. It was the fourth consecutive month where med-tech financings exceeded the $1 billion threshold, just slightly down from the $1.07 billion raised in December.
Read More

Med-tech gainers and losers for Jan. 22-26, 2024

Jan. 29, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Jan. 15-19, 2024

Jan. 22, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More
med-tech-deals-dec23-2.jpg
Med-tech deals December 2023

Med-tech deal value highest on record, climbs 33% YOY as M&As falter

Jan. 17, 2024
By Amanda Lanier
December med-tech deals totaled $220 million, down 50.25% from $442.2 million raised in November. However, for the full year 2023, med-tech deal value reached $10.63 billion, the top year in BioWorld’s records going back to 2018, and up 33.1% from 2022’s $7.99 billion.
Read More

Med-tech gainers and losers for Jan. 8-12, 2024

Jan. 16, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Jan. 1-5, 2024

Jan. 8, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More
Med-tech financings December 2023

$1B raised in December, but 2023 med-tech financings down 54%

Jan. 5, 2024
By Amanda Lanier
Med-tech financings exceeded $1 billion for the third consecutive month, reaching a total of $1.07 billion in transactions in December. In November, med-techs raised $1.02 billion, with $1.23 billion raised in October. The overall average for financings in 2023 stands at $1.47 billion per month, down from a monthly average of $3.19 billion the previous year.
Read More

Med-tech gainers and losers for Dec. 26-29, 2023

Jan. 2, 2024
The top 10 med-tech stock gainers and losers for the week.
Read More
Previous 1 2 … 19 20 21 22 23 24 25 26 27 … 55 56 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 26, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 26, 2026
  • Microscopy of a cross-section of mouse skin containing melanoma tumors

    Researchers identify innate immune barrier against melanoma

    BioWorld
    Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
  • Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers

    BioWorld Science
    Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
  • In the clinic for May 26, 2026

    BioWorld
    Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing